CClinicalTrials.gg
Status unknownNCT01231152Updated May 25, 2012

The Impact of Obesity on Children and Adolescents.

An observational study in Obesity and Cardiovascular Risk Factors, sponsored by University of Athens. Status unknown at 1 site in Greece. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2012-05-25.

Sponsored by University of Athens · Observational

The sponsor has not verified this record recently (last verified May 2012), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
80
Ages
8 Years to 18 Years
Sex
All
01

Study summary

The aim of the study is to investigate the association of obesity with arterial blood pressure, atherosclerosis, target organ damage (heart, arteries, kidney) and insulin resistance in children and young adolescents.

02

Conditions studied

  • Obesity
  • Cardiovascular Risk Factors

Browse trials for

03

In context

Obesity

6,297 studies on the registry are indexed under Obesity; 1,693 are open to participants now.

This study's planned enrollment of 80 is below the median of 135 across 1,283 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Athens is the lead sponsor of 133 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children and adolescents referred for increased body weight.

Inclusion criteria

  • Overweight (85th\<BMI\<95th percentile) and obese (BMI>=95th percentile) children and adolescents
  • No medication treatment (apart from bronchodilators, T4 in euthyroid children)
  • No severe mental problem
  • Parents' and patients' signed consent

Exclusion criteria

Exclusion Criteria:

  • Severe chronic or acute cardiac disease or other severe chronic or acute disease
  • Any acute inflammation
  • Familial dyslipidemia
  • Clinical hypothyroidism or other endocrinopathy
  • Poor compliance.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
80 participants (estimated)
06

What researchers measure

Primary outcomes

  1. Blood Pressure levels, Target organ damage (Left Ventricular Hypertrophy, IMT, pulse wave velocity, microalbuminuria), Insulin Resistance

    Time frame: 3 weeks

07

Study locations

1 of 1 sites recruiting
  • Hypertension Center, Third Department of Medicine, University of Athens
    Athens, Greece
    • George S Stergiou, MD · Contact · gstergi@med.uoa.gr · +302107763117
    • George S Stergiou, MD · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 25, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01231152
Lead sponsor
University of Athens
Responsible party
George S. Stergiou (Associate Professor of Medicine and Hypertension, University of Athens) — Principal investigator
First posted
Nov 1, 2010
Start date
Sep 2010
Primary completion
Dec 2012 (estimated)
Completion
Dec 2012 (estimated)
Last update
May 25, 2012

Study contacts

George S Stergiou
principal investigator · University of Athens

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion